rs752176040
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_019026.6(TMCO1):c.139_140delAG(p.Ser47fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.000255 in 1,612,874 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 0 hom. )
Consequence
TMCO1
NM_019026.6 frameshift
NM_019026.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.86
Genes affected
TMCO1 (HGNC:18188): (transmembrane and coiled-coil domains 1) This locus encodes a transmembrane protein. Mutations at this locus have been associated with craniofacial dysmorphism, skeletal anomalies, and cognitive disability. Mutations at this locus have also been associated with open angle glaucoma blindness. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-165768199-ACT-A is Pathogenic according to our data. Variant chr1-165768199-ACT-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 420165.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMCO1 | NM_019026.6 | c.139_140delAG | p.Ser47fs | frameshift_variant | 2/7 | ENST00000367881.11 | NP_061899.3 | |
TMCO1 | NM_001256164.1 | c.190_191delAG | p.Ser64fs | frameshift_variant | 2/7 | NP_001243093.1 | ||
TMCO1 | NM_001256165.1 | c.103_104delAG | p.Ser35fs | frameshift_variant | 2/7 | NP_001243094.1 | ||
TMCO1 | NR_045818.1 | n.233_234delAG | non_coding_transcript_exon_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMCO1 | ENST00000367881.11 | c.139_140delAG | p.Ser47fs | frameshift_variant | 2/7 | 1 | NM_019026.6 | ENSP00000356856.6 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 151698Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
38
AN:
151698
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251400Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135882
GnomAD3 exomes
AF:
AC:
28
AN:
251400
Hom.:
AF XY:
AC XY:
21
AN XY:
135882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000256 AC: 374AN: 1461176Hom.: 0 AF XY: 0.000246 AC XY: 179AN XY: 726936
GnomAD4 exome
AF:
AC:
374
AN:
1461176
Hom.:
AF XY:
AC XY:
179
AN XY:
726936
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000250 AC: 38AN: 151698Hom.: 0 Cov.: 32 AF XY: 0.000270 AC XY: 20AN XY: 74080
GnomAD4 genome
AF:
AC:
38
AN:
151698
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
74080
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 09, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Oct 22, 2019 | The variant was confirmed as compound heterozygous with a variant of uncertain significance (NM_019026.4: c.197C>T). - |
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Jul 05, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 19, 2020 | The c.292_293delAG (p.Ser98X) variant in TMCO1 has been reported (as c.139_140delAG: p.Ser47Ter) in the homozygous state in at least 5 individuals of Amish ancestry and in 2 additional unrelated individuals with Cerebro-facio-thoracic dysplasia, and segregated with disease in 2 affected members from 1 family (Xin 2010 PMID:20018682, Yates 2018 PMID:30556256). It has also been reported in ClinVar (Variation ID 420165). It has been identified in 0.02 (21/129086) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant creates a premature termination codon at position 98, which is predicted to lead to a truncated or absent protein. Loss of function of the TMCO1 gene is associated with autosomal recessive cerebro-facio-thoracic dysplasia. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive cerebro-facio-thoracic dysplasia. ACMG/AMP Criteria applied: PM2, PVS1_Moderate, PP1, PM3_Strong. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 05, 2010 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 25, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31028937, 20018682, 31102500, 30556256) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | TMCO1: PVS1, PM2, PM3 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | This sequence change creates a premature translational stop signal (p.Ser98*) in the TMCO1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TMCO1 are known to be pathogenic (PMID: 20018682, 23320496, 24194475, 24424126). This variant is present in population databases (rs752176040, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with craniofacial dysmorphism, skeletal anomalies, and mental retardation (PMID: 20018682). It has also been observed to segregate with disease in related individuals. This variant is also known as c.139_140delAG. ClinVar contains an entry for this variant (Variation ID: 420165). For these reasons, this variant has been classified as Pathogenic. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2020 | The alteration results in a premature stop codon: _x000D_ _x000D_ The c.139_140delAG (p.S47*) alteration, located in coding exon 2 of the TMCO1 gene, results from the deletion of 2 nucleotides from position 139 to 140, causing a translational frameshift with a predicted alternate stop codon at amino acid position 47. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. The alteration is rare in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the c.139_140delAG alteration was observed in 0.0103% (29/282,676) of total alleles studied. No homozygotes were reported in gnomAD. The alteration has been observed in affected individuals:_x000D_ _x000D_ The c.139_140delAG (p.S47*) alteration in TMCO1 has been reported homozygous in multiple patients of different ethnicities with cerebrofaciothoracic dysplasia (Xin, 2010; Yates, 2019). Based on the available evidence, this alteration is classified as pathogenic. - |
TMCO1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 25, 2023 | The TMCO1 c.292_293delAG variant is predicted to result in premature protein termination (p.Ser98*). This variant was reported the homozygous state in six individuals from an Old Order Amish family, all with craniofacial dysmorphism, skeletal anomalies, and intellectual disability; the variant was shown to segregate with disease within the family (variant described as c.139_140delAG, p.Ser47Ter in Xin et al. 2010. PubMed ID: 20018682). Further testing of undiagnosed children identified five additional Amish individuals with a similar phenotype, all homozygous for the c.292_293delAG (p.Ser98*) variant (Xin et al. 2010. PubMed ID: 20018682). This variant has also been reported in the homozygous state in three Pakistani brothers and one Scottish individual, all with craniofacial dysmorphism, skeletal anomalies, and intellectual disability (Yates et al. 2019. PubMed ID: 30556256). This variant is reported in 0.016% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-165737436-ACT-A). Other predicted loss-of-function variants in TMCO1 have been reported in affected individuals (Human Gene Mutation Database, https://www.hgmd.cf.ac.uk/). In summary, this variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at